PRESS RELEASE

MedChannels Announces the Release of OrderProTM

LAS VEGAS, NV, Jan. 4, 2006 /PRNewswire-FirstCall/ -- MedChannels, a state of Ohio limited liability corporation, has has announced the release of OrderPro , a handheld, physicians practice-based order entry and prescription compliance solution.

Working in conjunction with StatMedTMand the proprietary MaestroTMweb server, OrderPro, provides physicians with a prescription fulfillment service of unparalleled convenience.

OrderPro uses the latest wireless handheld computer technology to provide a tool to easily manage and quickly dispense drug products to patients in-house, generate clear and accurate printed prescriptions for the patient (or electronically fax a prescription directly to a pharmacy) all without leaving the exam room. For the first time OrderPro allows a physician to truly manage every aspect of an in-house dispensing program, including manufacturer samples and written prescriptions. OrderPro tracks every prescription written, sample or repackaged drug dispensed, reports tracking of ICD and CPT codes, inventory control and include an account reconciliation module. Its easy to use, takes no additional labor, and generates substantial revenues for a physician practice and/or multi-physician organization.

The release of OrderPro coincides with the recently approved Medicare Modernization Act and the prescription formulary is approved by the department of HHS. The company expects to be able to accept Medicare’s drug benefit cards when issued.

Physicians interested in participating in this unique program can download a marketing flyer from OrderPro.pdf . Alternatively, MedChannels can send hard copy sales and marketing information by emailing your request to: Mail OrderPro brochures or calling Martin James at 614-730-1345.

MedChannels is a leading provider of life science development and commercialization services with headquarters in Las Vegas, NV. Its principal activities are to provide integrated product development and commercial enrichment solutions to the pharmaceutical, biotechnology and medical device industries. The Group operates in three business segments, namely Product Development, Commercialization Services and the Informatics group. The Product Development group is primarily responsible for all phases of pre-clinical and clinical research. The Commercialization Services group is primarily responsible for sales force deployment and strategic marketing services including healthcare policy research and consulting services. The Informatics group is primarily responsible for providing market research solutions and strategic analyses to support healthcare decisions.


* * * * * * * * * * * * *
Statements in this release concerning expectations for the future are forward-looking statements. A variety of known and unknown risks, uncertainties and other factors could cause actual results, performance and expectations to differ materially from anticipated results, performance or expectations. These risks, uncertainties and other factors are discussed in the company's annual report and other documents filed from time to time with the appropriate regulatory agency.

http://tbutton.prnewswire.com/prn/b1690X77317545
SOURCE: MedChannels, Inc.
Web site: http: //www.medchannels.com
CONTACT: John Davidson, Investor Relations of MedChannels, Inc., +1-614-730-1345


* * * * * * * * * * * * *